Prof. Dr. med. Silke Gillessen Sommer
Adaptive Immuntherapie des fortgeschrittenen Prostatakarzinoms
Prikler L, Scandella E, Men Y, Engeler D, Diener P, Gillessen Sommer S, Ludewig B, Schmid H. Adaptive Immuntherapie des fortgeschrittenen Prostatakarzinoms - Cancer Testis Antigene (CTA) als mögliche Zielantigene. Aktuel Urol 2004; 35:326-330.
01.01.2004Adaptive Immuntherapie des fortgeschrittenen Prostatakarzinoms
01.01.2004Aktuel Urol 2004; 35:326-330
Prikler Ladislav, Scandella Elke, Men Ying, Engeler Daniel, Diener Pierre-André, Gillessen Sommer Silke, Ludewig Burkhard, Schmid Hans-Peter
Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma
Soiffer R, Mihm M, Webb I, Mulligan R, Neuberg D, Hardy S, Clift S, Bueno R, Jaklitsch M, Mentzer S, Duda R, Tanabe K, Singer S, Gillessen Sommer S, Jung K, Haluska F, Hodi F, Dranoff G. Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003; 21:3343-50.
01.09.2003Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma
01.09.2003Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003; 21:3343-50
Soiffer Robert, Mihm Martin, Webb Iain, Mulligan Richard, Neuberg Donna, Hardy Steve, Clift Shirley, Bueno Raphael, Jaklitsch Michael, Mentzer Steven, Duda Rosemary, Tanabe Kenneth, Singer Samuel, Gillessen Sommer Silke, Jung Ken, Haluska Frank, Hodi F Stephen, Dranoff Glenn
CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion
Gillessen Sommer S, Dranoff G, Strominger J, Balk S, Taniguchi M, Blumberg R, Luster A, Mach N, Lee F, Exley M, Nieuwenhuis E, Naumov Y, Wilson S. CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion. Proceedings of the National Academy of Sciences of the United States of America 2003; 100:8874-9.
22.07.2003CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion
22.07.2003Proceedings of the National Academy of Sciences of the United States of America 2003; 100:8874-9
Gillessen Sommer Silke, Dranoff Glenn, Strominger Jack L, Balk Steven P, Taniguchi Masaru, Blumberg Richard S, Luster Andrew D, Mach Nicolas, Lee Frederick S, Exley Mark A, Nieuwenhuis Edward E S, Naumov Yuri N, Wilson S Brian
Deficiencies of GM-CSF and interferon gamma link inflammation and cancer
Enzler T, Gillessen Sommer S, Manis J, Ferguson D, Fleming J, Alt F, Mihm M, Dranoff G. Deficiencies of GM-CSF and interferon gamma link inflammation and cancer. The Journal of experimental medicine 2003; 197:1213-9.
05.05.2003Deficiencies of GM-CSF and interferon gamma link inflammation and cancer
05.05.2003The Journal of experimental medicine 2003; 197:1213-9
Enzler Thomas, Gillessen Sommer Silke, Manis John P, Ferguson David, Fleming James, Alt Frederick W, Mihm Martin, Dranoff Glenn
Thalidomide: from tragedy to promise
von Moos R, Stolz R, Cerny T, Gillessen Sommer S. Thalidomide: from tragedy to promise. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:77-87.
08.02.2003Thalidomide: from tragedy to promise
08.02.2003Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2003; 133:77-87
von Moos Roger, Stolz Rahel, Cerny Thomas, Gillessen Sommer Silke
Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin
Jörger M, Öhlschlegel C, Cerny T, Gillessen Sommer S. Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin. Onkologie 2002; 25:558-61.
01.12.2002Postradiation high-grade myofibroblastic sarcoma of the prostate -- a rare entity of prostatic tumors -- responding to liposomal Doxorubicin
01.12.2002Onkologie 2002; 25:558-61
Jörger Markus, Öhlschlegel Christian, Cerny Thomas, Gillessen Sommer Silke
The proteasome, a new target for cancer therapy
Gillessen Sommer S, Groettup M, Cerny T. The proteasome, a new target for cancer therapy. Onkologie 2002; 25:534-9.
01.12.2002The proteasome, a new target for cancer therapy
01.12.2002Onkologie 2002; 25:534-9
Gillessen Sommer Silke, Groettup M, Cerny Thomas
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
Scandella E, Men Y, Gillessen Sommer S, Förster R, Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002; 100:1354-61.
15.08.2002Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
15.08.2002Blood 2002; 100:1354-61
Scandella Elke, Men Ying, Gillessen Sommer Silke, Förster Reinhold, Groettrup Marcus
Advances in the treatment of non-Hodgkin's lymphoma
Cerny T, Gillessen Sommer S. Advances in the treatment of non-Hodgkin's lymphoma. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002; 13 Suppl 4:211-6.
01.01.2002Advances in the treatment of non-Hodgkin's lymphoma
01.01.2002Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002; 13 Suppl 4:211-6
Cerny Thomas, Gillessen Sommer Silke
Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL
Li S, Gillessen Sommer S, Tomasson M, Dranoff G, Gilliland D, Van Etten R. Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL. Blood 2001; 97:1442-50.
01.03.2001Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL
01.03.2001Blood 2001; 97:1442-50
Li S, Gillessen Sommer Silke, Tomasson M H, Dranoff G, Gilliland D G, Van Etten R A
Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3
Tomasson M, Williams I, Li S, Kutok J, Cain D, Gillessen Sommer S, Dranoff G, Van Etten R, Gilliland D. Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3. Blood 2001; 97:1435-41.
01.03.2001Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3
01.03.2001Blood 2001; 97:1435-41
Tomasson M H, Williams I R, Li S, Kutok J, Cain D, Gillessen Sommer Silke, Dranoff G, Van Etten R A, Gilliland D G
Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity
Gillessen Sommer S, Mach N, Small C, Mihm M, Dranoff G. Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity. Blood 2001; 97:922-8.
15.02.2001Overlapping roles for granulocyte-macrophage colony-stimulating factor and interleukin-3 in eosinophil homeostasis and contact hypersensitivity
15.02.2001Blood 2001; 97:922-8
Gillessen Sommer Silke, Mach N, Small C, Mihm M, Dranoff G
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation
Teshima T, Mach N, Hill G, Pan L, Gillessen Sommer S, Dranoff G, Ferrara J. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Cancer research 2001; 61:162-71.
01.01.2001Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation
01.01.2001Cancer research 2001; 61:162-71
Teshima T, Mach N, Hill G R, Pan L, Gillessen Sommer Silke, Dranoff G, Ferrara J L
Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand
Mach N, Gillessen Sommer S, Wilson S, Sheehan C, Mihm M, Dranoff G. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer research 2000; 60:3239-46.
15.06.2000Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand
15.06.2000Cancer research 2000; 60:3239-46
Mach N, Gillessen Sommer Silke, Wilson S B, Sheehan C, Mihm M, Dranoff G
Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex
Presky D, Minetti L, Gillessen Sommer S, Wilkinson V, Wu C, Gubler U, Chizzonite R, Gately M. Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex. Journal of immunology (Baltimore, Md. : 1950) 1998; 160:2174-9.
01.03.1998Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex
01.03.1998Journal of immunology (Baltimore, Md. : 1950) 1998; 160:2174-9
Presky D H, Minetti L J, Gillessen Sommer Silke, Wilkinson V L, Wu C Y, Gubler U, Chizzonite R, Gately M K
Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia
Skoda R, Tichelli A, Tyndall A, Hoffmann T, Gillessen Sommer S, Gratwohl A. Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia. British journal of haematology 1997; 99:56-7.
01.10.1997Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia
01.10.1997British journal of haematology 1997; 99:56-7
Skoda R C, Tichelli A, Tyndall A, Hoffmann T, Gillessen Sommer Silke, Gratwohl A
Evidence for multiple sites of interaction between IL-12 and its receptor
Presky D, Minetti L, Gillessen Sommer S, Gubler U, Chizzonite R, Stern A, Gately M. Evidence for multiple sites of interaction between IL-12 and its receptor. Annals of the New York Academy of Sciences 1996; 795:390-3.
31.10.1996Evidence for multiple sites of interaction between IL-12 and its receptor
31.10.1996Annals of the New York Academy of Sciences 1996; 795:390-3
Presky D H, Minetti L J, Gillessen Sommer Silke, Gubler U, Chizzonite R, Stern A S, Gately M K
Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo
Gately M, Stern A, Familletti P, Faherty D, Podlaski F, Higgins G, Dwyer C, Wilkinson V, Kolinsky K, Warrier R, Gillessen Sommer S, Connaughton S, Carvajal D, Presky D. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Annals of the New York Academy of Sciences 1996; 795:1-12.
31.10.1996Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo
31.10.1996Annals of the New York Academy of Sciences 1996; 795:1-12
Gately M K, Stern A S, Familletti P C, Faherty D A, Podlaski F J, Higgins G F, Dwyer C M, Wilkinson V L, Kolinsky K D, Warrier R R, Gillessen Sommer Silke, Connaughton S E, Carvajal D M, Presky D H
Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist
Gillessen Sommer S, Stern A, Presky D, Gubler U, Familletti P, Stremlo D, Podlaski F, Ling P, Carvajal D, Gately M. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. European journal of immunology 1995; 25:200-6.
01.01.1995Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist
01.01.1995European journal of immunology 1995; 25:200-6
Gillessen Sommer Silke, Stern A S, Presky D H, Gubler U, Familletti P C, Stremlo D L, Podlaski F J, Ling P, Carvajal D, Gately M K
Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid
Laudiero L, Aloe L, Levi-Montalcini R, Buttinelli C, Schilter D, Gillessen Sommer S, Otten U. Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid. Neuroscience letters 1992; 147:9-12.
23.11.1992Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid
23.11.1992Neuroscience letters 1992; 147:9-12
Laudiero L B, Aloe L, Levi-Montalcini R, Buttinelli C, Schilter D, Gillessen Sommer Silke, Otten U